Small-molecule inhibitors targeting INK4 protein p18 INK4C enhance ex vivo expansion of haematopoietic stem cells
Yingdai Gao,Peng Yang,Hongmei Shen,Hui Yu,Xianmin Song,Liyan Zhang,Peng Zhang,Haizi Cheng,Zhaojun Xie,Sha Hao,Fang Dong,Shihui Ma,Qing Ji,Patrick Bartlow,Yahui Ding,Lirong Wang,Haibin Liu,Yanxin Li,Hui Cheng,Weimin Miao,Weiping Yuan,Youzhong Yuan,Tao Cheng,Xiang-Qun Xie
DOI: https://doi.org/10.1038/ncomms7328
IF: 16.6
2015-01-01
Nature Communications
Abstract:Among cyclin-dependent kinase inhibitors that control the G1 phase in cell cycle, only p18 and p27 can negatively regulate haematopoietic stem cell (HSC) self-renewal. In this manuscript, we demonstrate that p18 protein is a more potent inhibitor of HSC self-renewal than p27 in mouse models and its deficiency promoted HSC expansion in long-term culture. Single-cell analysis indicated that deleting p18 gene favoured self-renewing division of HSC in vitro . Based on the structure of p18 protein and in-silico screening, we further identified novel small-molecule inhibitors that can specifically block the activity of p18 protein. Our selected lead compounds were able to expand functional HSCs in a short-term culture. Thus, these putative small-molecule inhibitors for p18 protein are valuable for further dissecting the signalling pathways of stem cell self-renewal and may help develop more effective chemical agents for therapeutic expansion of HSC.